Business

Harvest One Announces New Satipharm Supply Agreement

Harvest One Announces New Satipharm Supply Agreement Canada NewsWire VANCOUVER, ...

articleDelivra Health Brands IncJune 6, 20195/company/delivra-health-brands-inc/news/harvest-one-announces-new-satipharm-supply-agreement
Harvest One Announces New Satipharm Supply Agreement

About this update from Delivra Health Brands Inc

[{"type":"text","content":"\n\n\n\nHarvest One Announces New Satipharm Supply Agreement\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\n\nCanada NewsWire\nVANCOUVER, June 6, 2019\n\n\n\nAgreement with Holland & Barrett will supply Satipharm CBD Gelpell® Capsules throughout UK and Ireland in 841 retail stores.\n VANCOUVER, June 6, 2019 /CNW/ - British Columbia – Harvest One Inc. (\"Harvest One\" or the \"Company\") (TSXV: HVT; OTCQX: HRVOF), through it's wholly-owned subsidiary Satipharm Ltd. (\"Satipharm\") today announced that it has entered into an agreement to distribute their proprietary Satipharm CBD 10mg Gelpell® through Holland & Barrett, Europe's largest retailer of nutritional supplements and wellness products with over 145 years of experience in the health and wellness industry. \n\n \n \n\n \nUnder the terms of the agreement, Harvest One will supply Satipharm CBD 10mg Gelpell® to 841 Holland Barrett stores and online via the Holland & Barret website. An initial shipment, which arrived on June 5th, 2019, will be distributed to stores across the UK. Satipharm will be supporting this increase in distribution with education and product training.  \n\"This supply agreement is pivotal to our global strategy. Having a European health and wellness leader like Holland & Barrett trust and carry our product shows the investment in our manufacturing standards and commercial strategy is proving a success\" said Grant Froese, CEO of Harvest One. \"We plan to build on this valued agreement by growing the demand for Satipharm CBD Gelpell® capsules through both instore and online activity.\"\n\"The CBD industry is growing rapidly. We will continue to be at the forefront of that growth through the release of innovative products that can add value to the market\" said a spokesperson for Holland & Barrett. \"Satipharm CBD Gelpell® capsules give our customers a consistent measurable dose of CBD that can be easily taken throughout their day.\"\nSatipharm does CBD differently. Satipharm CBD Gelpell® c...

More updates from Delivra Health Brands Inc